TOP 10 COMPANIES IN CLINICAL LAB AUTOMATION MARKET

The Clinical Lab Automation Market is expected to grow at a CAGR of 7.8% from 2023 to 2030 to reach $3.72 billion by 2030. The growth of this market can be attributed to the rising global geriatric population, the increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. However, the high costs of advanced clinical lab automation equipment, coupled with funding and infrastructure limitations in developing countries, restrain the growth of this market.

Furthermore, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to create market growth opportunities. However, factors such as high equipment maintenance and repair costs and concerns over the security and privacy of patient data pose challenges for the market’s growth.

Here are the top 10 companies operating in the Clinical Lab Automation Market

Danaher Corporation (U.S.)

Founded in 1969 and headquartered in Washington, D.C., Danaher offers professional, medical, industrial, and commercial products and services. The company operates through four reportable segments, namely, Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company operates in the clinical lab automation market through these segments.

The Diagnostics business segment offers a wide range of clinical instruments, reagents, consumables, software, and services. These products are used across hospitals, physicians’ offices, reference laboratories, and other critical care settings. The Life Sciences segment offers a broad range of instruments and consumables that are primarily used to study genes, proteins, metabolites, and cells, using various technologies and instruments such as flow cytometry, mass spectrometry, microscopy, gene therapy, and lab automation, among others.

The company has a presence in over 60 countries. Besides the U.S., the company has a significant presence in China, Denmark, Germany, Singapore, Sweden, Switzerland, and the U.K. Further, manufacturing facilities of the Diagnostics segment are located in North America, Europe, Asia, and Australia. AB Sciex LLC (Delaware), AB Sciex LP (Canada), Beckman Coulter Canada LP (Canada), Beckman Coulter France S.A.S. (France), and Danaher (Shanghai) Management Co Ltd. (China), among others, are a few of the subsidiaries operating in the clinical lab automation market.

Hamilton Company (U.S.)

Founded in 1953 and headquartered in Nevada, U.S., Hamilton Company is engaged in the development, manufacture, and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. The company’s offerings are categorized into Automation, Laboratory Process, and OEM. The company offers products in the clinical lab automation market through the Automation category.

The company has a direct geographical presence in the U.S., Australia, Europe, and Switzerland through its offices. Some of the company’s subsidiaries are Hamilton Company Japan K.K. (Japan), Hamilton (Shanghai) Laboratory Equipment Co., Ltd. (China), Hamilton France SARL (France), Hamilton Germany GmbH (Germany), and Hamilton Italia S.R.L. (Italy).

Abbott Laboratories (U.S.)

Founded in 1888 and headquartered in Illinois, U.S., Abbott Laboratories is engaged in the discovery, development, manufacturing, and sales of healthcare products. The company offers a wide range of products in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals markets. Abbott operates worldwide through four business segments, namely, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The company operates in the clinical lab automation market through the Diagnostics Products segment, which is further divided into Core Laboratory, Rapid Diagnostics, Point of Care, and Molecular business segments. The Rapid Diagnostics business is a part of Alere, Inc. (U.S.), a diagnostic device manufacturer and service provider, which Abbott acquired in 2017.

Abbott Laboratories has a wide geographic presence and a strong distribution network through direct and indirect channels in various countries. The company has 90 manufacturing facilities globally, of which 24 manufacturing sites are engaged in developing diagnostic products. Some of its subsidiaries operating all over the world include Abbott Molecular, Inc. (Delaware), Abbott Laboratories International LLC (U.S.), Abbott Rapid Diagnostics PTY LTD. (Australia), Abbott Rapid Diagnostics ULC (Canada), Abbott Rapid Diagnostics S.A.S. (France), Abbott Diagnostics GmbH (Germany), Abbott Products Unlimited Company (Ireland), Abbott Diagnostics Medical Co., Ltd. (Japan), Abbott Rapid Diagnostics Holding B.V. (Netherlands), Abbott Rapid Diagnostics Schweiz GmbH (Switzerland), Abbott Rapid Diagnostics AB (Sweden), PT. Abbott Indonesia (Indonesia), and Alere Diagnostics GmbH (Germany).

F. Hoffmann-La Roche AG (Switzerland)

Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche AG is a company dealing in pharmaceuticals and diagnostics. They have differentiated medicines for oncology, immunology, infectious disease, ophthalmology, and central nervous system diseases. They also provide in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management.

Roche’s operates through two segments: Pharmaceuticals and Diagnostics. The Pharmaceuticals segment is further sub-segmented into Roche Pharmaceuticals and Chugai, and the Diagnostics segment is divided into Core Lab, Molecular Lab, Point of Care Lab, Pathology Lab, and Diabetes Care. The company operates in the clinical lab automation market through the Diagnostics segment.

The company has a geographical presence across the U.S., Germany, Switzerland, Japan, China, New Zealand, India, Australia, Latin America, and Africa. The company has 33 research and development sites and 20 manufacturing sites worldwide in the Pharmaceuticals and Diagnostics segments. Some of the company’s subsidiaries are Roche Diabetes Care Austria GmbH (Austria), Roche Diabetes Care Brasil Ltda (Brazil), Hoffmann-la Roche Limited (Canada), Roche Diagnostics [Hongkong] Limited (China), Roche Pharmaceuticals A/S (Denmark), Roche Diabetes Care France SAS (France), Roche Diabetes Care Deutschland GmbH (Germany), and Roche Diabetes Care India Private Limited (India).

Thermo Fisher Scientific Inc. (U.S.)

Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher offers products and services in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, government, and academic sectors. The company operates through four segments: Life Science Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.

The company’s offerings cater to pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research & academic institutions, and government firms.

The company has a strong geographic presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa through its subsidiaries, R&D sites, and a strong distribution network. As of December 2022, the company has a headcount of 130,000 employees, of which 67,000 were employed in the Americas, 21,000 in the Asia-Pacific, and 42,000 in Europe and the Middle East & Africa. Some of its major subsidiaries are Molecular Probes, Inc. (U.S.), Thermo Electron North America LLC (U.S.), and European Laboratory Holdings Limited (U.K.).

Meticulous Research in its latest publication on Clinical Lab Automation Market has predicted the growth of 7.8% during the forecast year 2023-2030. 

Siemens Healthineers AG (Germany)

Founded in 1847 and headquartered in Erlangen, Germany, Siemens Healthineers AG is a provider of healthcare solutions and services. The company operates through four different segments, namely, Imaging, Diagnostics, Varian, and Advanced Therapies. The company operates in the clinical lab automation segment through the Diagnostics segment. This segment offers PCR systems, immunoassays, and solutions for efficient workflow.

The company has a direct presence in more than 70 countries, with main manufacturing sites in the U.S., China, and Germany. The company produces, develops, and sells various therapeutic and diagnostic services and products to healthcare providers in over 180 countries.

Some of its subsidiaries operating in the diagnostics segment are Siemens Healthcare Diagnostics Products GmbH (Germany), Siemens Healthcare Diagnostics GmbH (Austria), Siemens Healthcare Diagnostics Ltd. (United Kingdom), Siemens Healthcare Diagnostics Manufacturing Limited (Ireland), Siemens Healthcare Diagnostics Manufacturing Limited (U.K.), Siemens Healthcare Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics S.A. (Costa Rica), and Siemens Healthcare Diagnostics (Mexico).

Agilent Technologies, Inc. (U.S.)

Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. offers application-focused solutions such as software, consumables, services, and instruments for laboratory workflow. The company operates through three business segments, namely, Life Sciences and Applied Market, Diagnostics and Genomics, and Agilent CrossLab. The company operates in the clinical lab automation market through the Life Sciences and Applied Market segment.

The Life Sciences and Applied Market segment provides application-based solutions that allow customers to identify, quantify, and analyze the physical and biological properties of substances and provide instruments like liquid chromatography, gas chromatography, mass spectrometry, spectroscopy, lab automation, robotics, and related agents; and software & informatics.

Agilent Technologies, Inc. sells its products primarily through direct sales channels and also through resellers, e-commerce platforms, distributors, and manufacturers’ representatives. The company has manufacturing sites and primary R&D facilities in Washington, California, Delaware, Massachusetts, and Texas, among others.

Major subsidiaries of the company are Agilent LED International (California), Agilent Technologies World Trade, Inc. (Delaware), Objective Systems Integrators, S.A. de C.V. (Mexico), Agilent Technologies Australia Pty Ltd (Australia), Agilent Technologies Italia S.p.A (Italy), Agilent Technologies Rhone SarL (Singapore), Yokogawa Analytical Systems, Inc. (Japan), and Agilent Technologies Deutschland Holding GmbH (Germany).

Tecan Group Ltd. (Switzerland)

Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group Ltd. is engaged in the development, production, marketing, and support of automated laboratory instruments and solutions for applications in biopharmaceuticals, forensics, and clinical diagnostics. The company provides its products to pharmaceutical and biotechnology companies, university research departments, and diagnostic laboratories. The company operates through two reportable segments: Life Sciences Business and Partnering Business. The company operates in the clinical lab automation market through the Life Sciences Business segment.

Tecan Group’s Life Sciences Business has a wide geographic presence and distributes its products through its market organizations and distributors in more than 70 countries globally. Some of the company’s subsidiaries are Tecan Genomics, Inc. (U.S.), Tecan France S.A.S (France), Tecan Italia S.r.l. (Italy), Tecan UK Ltd. (U.K.), Tecan Japan Co., Ltd. (Japan), and Tecan Australia Pty Ltd. (Australia).

Becton, Dickinson, and Company (U.S.)

Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson, and Company (BD) is a medical technology company that manufactures and sells a wide range of medical devices, laboratory equipment, and diagnostic products used by healthcare institutions, clinical laboratories, pharmaceutical companies, and research centers. The company operates through three business segments, namely, BD Medical, BD Life Sciences, and BD Interventional. The company operates in the clinical lab automation market through the BD Life Sciences segment.

The BD Life Sciences segment offers products through two major categories, namely, Diagnostic Solutions (Diagnostic Systems and Preanalytical Systems) and Biosciences. The Diagnostic Systems category offers numerous products with clinical and industrial applications. These products include molecular testing systems for infectious diseases & women’s health, liquid-based cytology systems for cervical cancer screening, culturing systems, rapid diagnostic assays for testing respiratory infections, microorganism identification, and drug susceptibility systems.

BD has a direct presence in the U.S., Brazil, Canada, China, France, Spain, the U.K., Germany, Hungary, India, Ireland, Israel, Italy, Japan, Mexico, Singapore, and the Netherlands through its manufacturing and sales operations. The R&D facilities of the company are located in China, France, India, Ireland, the U.S., and Singapore. BD has a wide global distribution network and markets its products through independent sales representatives.

Major subsidiaries of the company include Becton Dickinson Canada, Inc. (Canada), BD Holding S. de R.L. de C.V. (Mexico), Becton Dickinson Infusion Therapy B.V. (Netherlands), Becton Dickinson Biosciences, Systems and Reagents Inc. (U.K.), Becton Dickinson Hungary Kft. (Hungary), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), Becton Dickinson India Private Limited (India), and BDIT Singapore Pte. Ltd. (Singapore).

Waters Corporation (U.S.)

Founded in 1958 and headquartered in Massachusetts, U.S., Waters Corporation is a specialty measurement company that designs, manufactures, sells, and provides services for high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and comprehensive post-warranty service plans. The company also develops and supplies advanced software-based products that interface with its instruments.

Waters Corporation operates through two business segments, namely, Waters and TA. The Waters segment operates in the clinical lab automation market and is engaged in designing, manufacturing, selling, and servicing LC and MS instruments. The TA segment designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments.

The company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic, and governmental organizations. Its LC columns are manufactured and distributed through facilities in Taunton (U.K.), Massachusetts (U.S.), and Wexford (Ireland).

The company has subsidiaries in Australia, Brazil, Canada, China, France, Germany, Hongkong, Ireland, and the Netherlands and operates its business through 19 U.S. facilities and 69 international facilities, including field offices. Some of its primary facilities are in the U.S., Australia, Canada, China, England, France, Germany, Ireland, India, Netherlands, Romania, and Singapore. Some of its subsidiaries are Waters Technologies Corporation (U.S.), Water Australia PTY LTD. (Australia), Waters Kft (Hungary), and Waters GmbH (Germany).

Authoritative Research on the Clinical Lab Automation Market – Global Opportunity Analysis and Industry Forecast (2023-2030)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.